Raiffeisen Bank International’s Recursion Pharmaceuticals RXRX Stock Holding History

Raiffeisen Bank International’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$454K	Buy	160,000 +10,000	+7%	+$38.6K	0.01%	459
2025 Q4	$617K	Buy	150,000 +10,000	+7%	+$49.5K	0.01%	416
2025 Q3	$687K	Buy	140,000 +10,000	+8%	+$52.5K	0.01%	391
2025 Q2	$671K	Hold	130,000	–	–	0.01%	330
2025 Q1	$755K	Sell	130,000 -20,000	-13%	-$146K	0.01%	309
2024 Q4	$1.02M	Buy	+150,000	New	+$1.01M	0.02%	271

Other funds holding RXRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raiffeisen Bank International's RXRX Position: Q1 2026 in Review

Raiffeisen Bank International increased its Recursion Pharmaceuticals (RXRX) stake by 6.7% in Q1 2026, buying an estimated $38.6K and bringing the position to 160,000 shares worth $454K. The position accounts for 0.01% of the portfolio, ranked #459.

Raiffeisen Bank International first reported a position in RXRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.02M in Q4 2024. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

Raiffeisen Bank International held 160,000 shares of Recursion Pharmaceuticals worth $454K as of Q1 2026.
Raiffeisen Bank International bought 10,000 Recursion Pharmaceuticals shares in Q1 2026, an estimated $38.6K.
Recursion Pharmaceuticals made up 0.01% of Raiffeisen Bank International's portfolio in Q1 2026, its #459 holding.
Raiffeisen Bank International first reported a position in Recursion Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
Raiffeisen Bank International's Recursion Pharmaceuticals position peaked at $1.02M in Q4 2024.
334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.